News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
666,567 Results
Type
Article (62461)
Company Profile (77)
Press Release (604019)
Multimedia
Podcasts (103)
Webinars (21)
Section
Business (174100)
Career Advice (2749)
Deals (32531)
Drug Delivery (116)
Drug Development (77199)
Employer Resources (154)
FDA (15167)
Job Trends (13951)
News (305947)
Policy (29125)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (2)
Academia (2909)
Academic (2)
Accelerated approval (32)
Adcomms (28)
Allergies (142)
Alliances (43289)
ALS (167)
Alzheimer's disease (1605)
Antibody-drug conjugate (ADC) (290)
Approvals (15442)
Artificial intelligence (528)
Autoimmune disease (160)
Automation (38)
Bankruptcy (291)
Best Places to Work (10859)
BIOSECURE Act (16)
Biosimilars (176)
Biotechnology (55)
Bladder cancer (154)
Brain cancer (60)
Breast cancer (624)
Cancer (4700)
Cardiovascular disease (393)
Career advice (2347)
Career pathing (40)
CAR-T (286)
CDC (45)
Celiac Disease (2)
Cell therapy (761)
Cervical cancer (35)
Clinical research (66097)
Collaboration (1647)
Company closure (5)
Compensation (712)
Complete response letters (57)
COVID-19 (2683)
CRISPR (92)
C-suite (900)
Cystic fibrosis (144)
Data (6111)
Decentralized trials (2)
Denatured (41)
Depression (132)
Diabetes (470)
Diagnostics (6469)
Digital health (45)
Diversity (13)
Diversity, equity & inclusion (40)
Drug discovery (245)
Drug pricing (185)
Drug shortages (25)
Duchenne muscular dystrophy (212)
Earnings (63253)
Editorial (59)
Employer branding (18)
Employer resources (138)
Events (98763)
Executive appointments (1032)
FDA (18265)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (9)
Frontotemporal dementia (23)
Funding (1458)
Gene editing (200)
Generative AI (44)
Gene therapy (573)
GLP-1 (909)
Government (4706)
Grass and pollen (7)
Guidances (380)
Healthcare (18265)
HIV (56)
Huntington's disease (39)
IgA nephropathy (78)
Immunology and inflammation (223)
Immuno-oncology (53)
Indications (103)
Infectious disease (2938)
Inflammatory bowel disease (186)
Inflation Reduction Act (13)
Influenza (115)
Intellectual property (245)
Interviews (530)
IPO (14911)
IRA (45)
Job creations (3419)
Job search strategy (1947)
JPM (62)
Kidney cancer (17)
Labor market (75)
Layoffs (591)
Leadership (36)
Legal (6473)
Liver cancer (84)
Longevity (12)
Lung cancer (625)
Lymphoma (362)
Machine learning (40)
Management (54)
Manufacturing (741)
MASH (163)
Medical device (13038)
Medtech (13087)
Mergers & acquisitions (18735)
Metabolic disorders (1205)
Multiple sclerosis (151)
NASH (13)
Neurodegenerative disease (302)
Neuropsychiatric disorders (86)
Neuroscience (2790)
Neurotech (1)
NextGen: Class of 2026 (6386)
Non-profit (4351)
Now hiring (21)
Obesity (549)
Opinion (290)
Ovarian cancer (161)
Pain (199)
Pancreatic cancer (223)
Parkinson's disease (273)
Partnered (33)
Patents (494)
Patient recruitment (504)
Peanut (58)
People (61211)
Pharmaceutical (19)
Pharmacy benefit managers (26)
Phase 1 (20830)
Phase 2 (29133)
Phase 3 (21273)
Pipeline (5094)
Policy (271)
Postmarket research (2476)
Preclinical (8855)
Press Release (67)
Prostate cancer (242)
Psychedelics (41)
Radiopharmaceuticals (280)
Rare diseases (817)
Real estate (6033)
Recruiting (66)
Regulatory (22271)
Reports (40)
Research institute (2465)
Resumes & cover letters (408)
Rett syndrome (28)
RNA editing (15)
RSV (66)
Schizophrenia (143)
Series A (240)
Series B (184)
Service/supplier (8)
Sickle cell disease (93)
Special edition (15)
Spinal muscular atrophy (155)
Sponsored (43)
Startups (3379)
State (1)
Stomach cancer (11)
Supply chain (86)
Tariffs (67)
The Weekly (60)
Vaccines (971)
Venture capital (78)
Weight loss (337)
Women's health (81)
Worklife (21)
Date
Today (187)
Last 7 days (581)
Last 30 days (2023)
Last 365 days (28481)
2026 (3212)
2025 (28688)
2024 (32300)
2023 (36349)
2022 (46633)
2021 (51571)
2020 (50725)
2019 (44793)
2018 (34063)
2017 (30739)
2016 (30078)
2015 (35449)
2014 (28408)
2013 (24977)
2012 (26226)
2011 (26465)
2010 (24945)
Location
Africa (886)
Alabama (84)
Alaska (6)
Arizona (238)
Arkansas (14)
Asia (39404)
Australia (7073)
California (10321)
Canada (3048)
China (1049)
Colorado (438)
Connecticut (441)
Delaware (325)
Europe (92035)
Florida (1553)
Georgia (343)
Hawaii (3)
Idaho (59)
Illinois (867)
India (65)
Indiana (473)
Iowa (22)
Japan (408)
Kansas (118)
Kentucky (39)
Louisiana (26)
Maine (74)
Maryland (1274)
Massachusetts (7288)
Michigan (333)
Minnesota (561)
Mississippi (6)
Missouri (137)
Montana (34)
Nebraska (26)
Nevada (113)
New Hampshire (76)
New Jersey (2871)
New Mexico (30)
New York (2811)
North Carolina (1402)
North Dakota (10)
Northern California (4977)
Ohio (317)
Oklahoma (23)
Oregon (42)
Pennsylvania (2038)
Puerto Rico (24)
Rhode Island (44)
South America (1189)
South Carolina (52)
South Dakota (1)
Southern California (4101)
Tennessee (167)
Texas (1649)
United States (37045)
Utah (319)
Vermont (1)
Virginia (256)
Washington D.C. (66)
Washington State (855)
West Virginia (4)
Wisconsin (120)
Wyoming (2)
666,567 Results for "university of barcelona".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ORYZON to Attend the 2025 Phelan-McDermid Syndrome (PMS) Congress in Barcelona on June 26-29
June 18, 2025
·
8 min read
Business
IMIDomics Establishes a License and Collaboration Partnership with the University of Barcelona to Advance Treatments for IMIDs
IMIDomics Inc. today announced a strategic license and collaboration agreement with the University of Barcelona (UB).
October 11, 2023
·
3 min read
Press Releases
IVIRMA Drives Global Dialogue on Reproductive Medicine at the 11th International Congress Held in Barcelona
April 22, 2025
·
3 min read
Press Releases
Integra Therapeutics, first company to move into Advanced Therapies Platform at SJD Barcelona Children’s Hospital
February 25, 2025
·
1 min read
Press Releases
First-of-its-kind Universal Clearance Establishes Maximum Regulatory Access to the Bezier Parametric Curve Spinal Rod System for Patients and Surgeons
February 5, 2026
·
2 min read
Drug Development
Twelve month Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis (FAP) to be Presented at Prestigious Biennial InSIGHT 2024 Meeting in Barcelona
Biodexa Pharmaceuticals PLC announces that 12 month data of a Phase 2 clinical trial of eRapa in Familial Adenomatous Polyposis are to be presented at the prestigious biennial InSIGHT 2024 meeting in Barcelona, Spain on June 22, 2024.
June 10, 2024
·
6 min read
BioNxt Solutions Reports on Barcelona CPHI Conference
BioNxt Solutions Inc. is pleased to report on a successful CPHI pharma conference in Barcelona, Spain, recently attended by BioNxt’s European team.
November 6, 2023
·
3 min read
Press Releases
QIAGEN Strengthens QIAstat-Dx With New Barcelona Site to Drive Growth in Infectious Diseases and Precision Medicine Testing
November 29, 2024
·
7 min read
ILiAD Biotechnologies Announces Presentation at the 2023 World Vaccine Congress in Barcelona
ILiAD Biotechnologies, LLC (ILiAD), a vaccine company utilizing its B-Tech technology to develop novel vaccines against infectious diseases, today announced Chief Medical Officer Stephanie Noviello, MD, MPH, will present data on its pertussis vaccine, BPZE1, at the World Vaccine Congress Europe in Barcelona, Spain (October 17 – 19, 2023).
October 18, 2023
·
4 min read
Biotech Bay
Pharmatech Associates Showcases Strategic Program Development for Drug Sponsors and Innovators at CPHI Barcelona 2023
This week at CPHI Barcelona, Pharmatech Associates will showcase its expertise and capabilities that help global pharmaceutical and emerging biotech companies accelerate their innovation and speed delivery of breakthrough medicines and therapies to patients.
October 24, 2023
·
5 min read
1 of 66,657
Next
